Predictors of Healthy Mood and Memory After Oophorectomy
Status: Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 29 Mar 2017
Price : $35 *
At a glance
- Drugs Estradiol (Primary) ; Lisdexamfetamine (Primary)
- Indications Cognition disorders; Memory disorders; Mood disorders
- Focus Pharmacodynamics
- Acronyms E2-LDX
- 21 Mar 2017 Status changed from active, no longer recruiting to withdrawn prior to enrolment because Funding was not obtained for this study and no participants were enrolled. .
- 12 Oct 2016 Planned End Date changed from 1 Jul 2015 to 1 Jun 2020.
- 12 Oct 2016 Planned primary completion date changed from 1 Jul 2015 to 1 Jun 2020.